Showing results (131-140 of 187) with videos related to
Sort By:
Pageof 19
Cancer Chemotherapy and Pharmacology|October 5, 2013
A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401In-Jae Oh, Kyu-Sik Kim, Young-Chul Kim, et al.Yonsei Medical Journal|March 30, 2023
Effective Timing of Introducing an Inpatient Smoking Cessation Program to Cancer PatientsYu-Ri Choe, Ji-Won Choi, Ju-Ri Jeong, et al.EJNMMI Research|September 27, 2015
A phase II clinical trial to investigate the effect of pioglitazone on (18)F-FDG uptake in malignant lesionsYeon-Hee Han, Seong Young Kwon, Jeonghun Kim, et al.Tuberculosis and Respiratory Diseases|July 28, 2017
Review of Sarcoidosis in a Province of South Korea from 1996 to 2014Min-Seok Kim, Cheol-Kyu Park, Hong-Joon Shin, et al.Thoracic Cancer|December 12, 2025
Extended Follow-Up Analysis of First-Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer: A Real-World Multicenter Prospective Cohort StudyYechan Song, Myeong Geun Choi, Yeon Joo Kim, et al.Thoracic Cancer|January 15, 2016
Efficacy and safety of docetaxel plus oxaliplatin as a first-line chemotherapy in patients with advanced or metastatic non-small cell lung cancerHeejung Ban, Kyu-Sik Kim, In-Jae Oh, et al.Thoracic Cancer|July 8, 2016
Pulmonary sclerosing pneumocytoma mimicking lung cancer: Case report and review of the literatureJung-Hwan Lim, Nuri Lee, Dae-Woong Choi, et al.Plos One|February 4, 2021
Hypersensitivity reactions to multiple anti-tuberculosis drugsHong-Joon Shin, Jin-Sun Chang, Min-Suk Kim, et al.Nature Communications|April 4, 2024
Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8<sup>+</sup> T cells in murine models of inflammationGil-Woo Lee, Young Ju Kim, Sung-Woo Lee, et al.Thoracic Cancer|May 16, 2018
Feasibility of re-biopsy and EGFR mutation analysis in patients with non-small cell lung cancerTae-Ok Kim, In-Jae Oh, Bo Gun Kho, et al.Pageof 19